Aldebaran Financial Inc. / LLY
Aldebaran Financial Inc.’s Eli Lilly & Co Position
Does Aldebaran Financial Inc. own Eli Lilly & Co (LLY)? Yes — 2.0K shares worth $2M (+1.71% of its 13F portfolio) as of Q1 2026, up from 1.9K shares the prior filed quarter.
Position Value
$2M
Q1 2026
Shares
2.0K
% of Portfolio
+1.71%
Quarters Held
23
currently held
Position History LLY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 2.0K | $2M | +1.71% |
| Q4 2025 | 1.9K | $2M | +1.85% |
| Q3 2025 | 1.8K | $1M | +1.34% |
| Q2 2025 | 1.4K | $1M | +1.24% |
| Q1 2025 | 1.3K | $1M | +1.26% |
| Q4 2024 | 1.3K | $976,586 | +1.14% |
| Q3 2024 | 1.1K | $968,332 | +1.14% |
| Q2 2024 | 723 | $654,590 | +0.86% |
| Q1 2024 | 613 | $476,889 | +0.67% |
| Q4 2023 | 603 | $351,501 | +0.52% |
| Q3 2023 | 603 | $323,889 | +0.51% |
| Q3 2022 | 1.2K | $378,000 | +0.42% |
| Q2 2022 | 1.2K | $372,000 | +0.39% |
| Q1 2022 | 1.2K | $333,000 | +0.26% |
| Q4 2021 | 1.1K | $293,000 | +0.22% |
| Q3 2021 | 1.1K | $245,000 | +0.20% |
| Q2 2021 | 1.1K | $245,000 | +0.20% |
| Q1 2020 | 5.8K | $812,000 | +0.79% |
| Q4 2019 | 5.8K | $769,000 | +0.58% |
| Q3 2019 | 5.8K | $649,000 | +0.43% |
| Q2 2019 | 5.8K | $648,000 | +0.45% |
| Q1 2019 | 5.8K | $759,000 | +0.53% |
| Q4 2018 | 5.8K | $677,000 | +0.52% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Aldebaran Financial Inc.’s full portfolio or all institutional holders of LLY.